Compounds > bromodeoxyuridine
Page last updated: 2024-08-17

bromodeoxyuridine and Cancer of Head

bromodeoxyuridine has been researched along with Cancer of Head in 49 studies

Research

Studies (49)

TimeframeStudies, this research(%)All Research%
pre-19908 (16.33)18.7374
1990's27 (55.10)18.2507
2000's11 (22.45)29.6817
2010's1 (2.04)24.3611
2020's2 (4.08)2.80

Authors

AuthorsStudies
Kirihata, M; Masunaga, SI; Ono, K; Sakurai, Y; Sanada, Y; Suzuki, M; Takata, T; Tanaka, H1
Abe, Y; Houri, A; Kurihara, M; Miyamoto, S; Mukudai, Y; Nara, M; Shimane, T; Shirota, T; Watanabe, M1
Banh, A; Bavan, B; Cao, H; Chen, CH; Ha, C; Jensen, K; Kaplan, MJ; Khong, B; Kong, CS; Koong, AC; Krakow, T; Kuo, P; Le, QT; Mochly-Rosen, D; Sirjani, D; Xiao, N; Yao, M1
Barberi-Heyob, M; Didelot, C; Merlin, JL; Mirjolet, JF1
Bussink, J; Denekamp, J; Kaanders, JH; Ljungkvist, AS; Rijken, PF; van der Kogel, AJ1
Dobrowsky, E; Dobrowsky, W; Wilson, GD1
Hori, H; Kinashi, Y; Masunaga, S; Nagasawa, H; Nagata, K; Ohnishi, K; Ohnishi, T; Ono, K; Suzuki, M; Takahashi, A; Uto, Y1
Hankins, JL; McLaughlin, PJ; Verderame, MF; Zagon, IS1
Hass, HG; Kaiser, S; Nehls, O; Schmidt, A1
Adachi, M; Hasegawa, Y; Ijichi, K; Ishizaki, K; Kudoh, A; Murakami, S; Nakamura, H; Ogawa, T; Yasui, Y1
Bagshaw, MA; Doggett, RL; Kaplan, HS; Nelsen, TS; Smith, KC1
Glatstein, E; Kinsella, TJ; Mitchell, JB; Morstyn, G; Russo, A1
Furusawa, M; Jimi, S; Mashiba, H; Matsunaga, K; Nomura, Y; Yagawa, K; Yoshinaga, H1
Caldarelli, DD; Coon, JS; Hutchinson, J; Kotelnikov, VM; LaFollette, S; Panje, W; Preisler, HD; Taylor, S1
Begg, AC1
Daley, FM; Dische, S; Richman, PI; Robinson, B; Ross, DA; Saunders, MI; Wilson, GD1
Caslin, AW; Cooke, LD; Cooke, TG; Forster, G; Jones, AS; Roland, NJ1
Cooke, LD; Cooke, TG; Forster, G; Jones, AS; Stell, PM1
Bacigalupo, A; Barra, S; Corvò, R; Geido, E; Giaretti, W; Margarino, G; Orecchia, R; Sanguineti, G; Vitale, V1
Abe, Y; Aoki, M; Kaimori, M; Mariya, Y; Takekawa, S; Tarusawa, N1
Dische, S; Saunders, MI; Wilson, GD1
Daley, FM; Dische, S; Joiner, B; Martindale, CA; Richman, PI; Robinson, BM; Saunders, MI; Wilson, GD1
Attal, P; Bobin, S; Bosq, J; Bourhis, J; Dendale, R; Eschwege, F; Fortin, A; Hill, C; Janot, F; Luboinski, B; Malaise, EP; Marandas, P; Schwaab, G; Wibault, P; Wilson, G1
Danova, M; Dionigi, P; Ferrari, C; Giordano, M; Mazzini, G; Riccardi, A1
Au, JL; Weaver, JR1
Baldetorp, B; Bendahl, PO; Fadeel, IA; Johansson, MC; Oredsson, SM1
Bussink, J; Kaanders, JH; Martindale, CA; Rijken, PF; van der Kogel, AJ1
Nin, F1
Caldarelli, DD; Coon JS, IV; Griem, K; Haleem, A; Hutchinson, J; Kotelnikov, VM; Panje, W; Preisler, HD; Taylor S, IV1
Antognoni, P; Awwad, H; Bartelink, H; Begg, AC; Bourhis, J; Corvo, R; Coucke, P; Dische, S; Dobrowsky, W; Giaretti, W; Gustaffson, H; Hart, AA; Haustermans, K; Horiot, JC; Hoyer, M; Jouffroy, T; Maciorowski, Z; Overgaard, J; Paschoud, N; Richetti, A; Saunders, M; Shouman, T; Struikmans, H; Wilson, GD; Zackrisson, B1
de Jong, JM; Engelen, JJ; Kleinjans, JC; Schilderman, PA; Welle, IJ; Zwingmann, IH1
Fowler, JF; Haustermans, K1
Cvetkovska, E; Edström, S; Westin, T; Young, C1
Hordijk, GJ; Kal, HB; Struikmans, H; van der Tweel, I1
Flygare, P; Gustafsson, H; Sjöström, B; Wilson, GD; Zackrisson, B1
Cook, JA; Epstein, AH; Glatstein, E; Goffman, T1
Banks, WL; Chan, WM; Collins, JM; Frank, JL; Lawrence, W; McKinnon, JG1
Bowie, G; Cooke, LD; Cooke, TG; Forster, G; Stanton, PD; Stell, PM1
Bennett, MH; Dische, S; Laing, JH; Leslie, MD; Martindale, CA; O'Halloran, AE; Robinson, BM; Saunders, MI; Wilson, GD1
Gluckman, JL; Hirano, T; Zitsch, RP1
Archibald, SD; Booker, L; Browman, GP; Daya, D; Goldsmith, CH; Kanclerz, A; Young, JE1
Armengot, M; Barona, R; Basterra, J; Garin, L; O'Connor, E1
Edström, SS; Gustafsson, B; Lydén, E; Stein, H; Stenman, G; Westin, T1
Hemmer, J1
Cho, EK; Chung, CH; Lee, SS; Lee, TS; Park, JS1
Hattori, T; Hirano, T; Murata, M; Nakagawa, T; Sakakura, Y; Tashiro, T; Toyota, S; Yamaguchi, N1
Kärcher, H; Kärcher, KH; McNally, NJ; Pfragner, R; Wilson, G1
Bagshaw, MA; Goffinet, DR1
Ishimori, S; Kagawa, M; Kanno, T; Moriyama, M; To, T1

Reviews

3 review(s) available for bromodeoxyuridine and Cancer of Head

ArticleYear
The clinical status of Tpot as a predictor? Or why no tempest in the Tpot!
    International journal of radiation oncology, biology, physics, 1995, Jul-30, Volume: 32, Issue:5

    Topics: Bromodeoxyuridine; Cell Division; Female; Head and Neck Neoplasms; Humans; Idoxuridine; Kinetics; Predictive Value of Tests; Treatment Outcome; Uterine Neoplasms

1995
[Determination of the phase of synthesis by means of bromodeoxyuridine. Its clinical application in oncology of the head and neck].
    Anales otorrinolaringologicos ibero-americanos, 1991, Volume: 18, Issue:6

    Topics: Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunohistochemistry; Microscopy, Fluorescence; S Phase

1991
Clinical use of radiation sensitizing agents.
    Cancer treatment reviews, 1974, Volume: 1, Issue:1

    Topics: Animals; Antimetabolites, Antineoplastic; Bleomycin; Bromodeoxycytidine; Bromodeoxyuridine; Bromouracil; Carcinoma, Squamous Cell; Dactinomycin; Dose-Response Relationship, Radiation; Floxuridine; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Idoxuridine; Neoplasms; Neoplasms, Experimental; Radiation-Sensitizing Agents

1974

Trials

4 trial(s) available for bromodeoxyuridine and Cancer of Head

ArticleYear
In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer.
    International journal of radiation oncology, biology, physics, 2003, Mar-01, Volume: 55, Issue:3

    Topics: Analysis of Variance; Antibiotics, Antineoplastic; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Mitomycin; Neoplasm Staging; Ploidies; Radiation-Sensitizing Agents; Survival Analysis

2003
The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers.
    International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:8

    Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Survival; Clinical Trials as Topic; Combined Modality Therapy; Cricetinae; DNA Repair; Head and Neck Neoplasms; Humans; Idoxuridine; Mice; Neoplasms; Radiation-Sensitizing Agents

1984
Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    International journal of radiation oncology, biology, physics, 1993, Dec-01, Volume: 27, Issue:5

    Topics: Actuarial Analysis; Adult; Age Factors; Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Kinetics; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Ploidies; Prognosis

1993
Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
    BJR supplement, 1992, Volume: 24

    Topics: Brain Neoplasms; Bromodeoxyuridine; Glioma; Head and Neck Neoplasms; Humans; Idoxuridine; Radiation-Sensitizing Agents; Sarcoma

1992

Other Studies

42 other study(ies) available for bromodeoxyuridine and Cancer of Head

ArticleYear
The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy.
    Journal of radiation research, 2023, Mar-23, Volume: 64, Issue:2

    Topics: Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Sulfhydryl Compounds; Tumor Suppressor Protein p53

2023
Suprabasin enhances the invasion, migration, and angiogenic ability of oral squamous cell carcinoma cells under hypoxic conditions.
    Oncology reports, 2023, Volume: 49, Issue:5

    Topics: Animals; Antigens, Differentiation; Bromodeoxyuridine; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Head and Neck Neoplasms; Humans; Hypoxia; Mice; Mouth Neoplasms; Neoplasm Proteins; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2023
A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Dec-01, Volume: 17, Issue:23

    Topics: Adult Stem Cells; Aldehyde Dehydrogenase; Allyl Compounds; Animals; Antigens, CD34; Antigens, Ly; Benzodioxoles; Bromodeoxyuridine; Enzyme Activation; Enzyme Activators; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Membrane Proteins; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-kit; RNA, Messenger; Submandibular Gland; Thy-1 Antigens; Xerostomia

2011
G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity.
    Cytometry, 2002, May-01, Volume: 48, Issue:1

    Topics: Adenocarcinoma; Antimetabolites; Antimetabolites, Antineoplastic; Breast Neoplasms; Bromodeoxyuridine; Coloring Agents; Female; Flow Cytometry; Fluorouracil; G1 Phase; Head and Neck Neoplasms; Humans; Pancreatic Neoplasms; Propidium; Resting Phase, Cell Cycle; S Phase; Tumor Cells, Cultured

2002
Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas.
    International journal of radiation oncology, biology, physics, 2002, Sep-01, Volume: 54, Issue:1

    Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Hypoxia; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous

2002
Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
    Cancer science, 2003, Volume: 94, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Hypoxia; Cisplatin; Combined Modality Therapy; DNA Damage; Gamma Rays; Genes, p53; Head and Neck Neoplasms; Humans; Hyperthermia, Induced; Mice; Mice, Inbred BALB C; Mice, Nude; Micronucleus Tests; Neoplasm Proteins; Paclitaxel; Radiation-Sensitizing Agents; Tirapazamine; Triazines; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2003
Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck.
    International journal of molecular medicine, 2007, Volume: 19, Issue:3

    Topics: Aged; Antibodies; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Cell Line, Tumor; Cell Proliferation; Clone Cells; DNA, Neoplasm; Down-Regulation; Enkephalin, Methionine; Gene Expression; Head and Neck Neoplasms; Humans; Kinetics; Male; Protein Binding; Protein Transport; Receptors, Opioid

2007
DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
    Oral oncology, 2008, Volume: 44, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Proliferation; DNA, Neoplasm; Female; Flow Cytometry; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Male; Middle Aged; Ploidies; Radiation-Sensitizing Agents

2008
Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells.
    Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:5

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cisplatin; Colony-Forming Units Assay; Flow Cytometry; Fluorouracil; Head and Neck Neoplasms; Humans; Immunohistochemistry; Neoplasms, Squamous Cell; Proliferating Cell Nuclear Antigen

2008
Intra-arterial 5-bromodeoxyuridine and x-ray therapy.
    The American journal of roentgenology, radium therapy, and nuclear medicine, 1967, Volume: 99, Issue:4

    Topics: Bromodeoxyuridine; Carbon Isotopes; Carcinoma, Squamous Cell; Carotid Arteries; DNA, Neoplasm; Facial Neoplasms; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Injections, Intra-Arterial; Male; Methotrexate; Mouth Neoplasms; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms

1967
Elevated cytostatic activity of monocytes from cancer patients.
    Gan, 1981, Volume: 72, Issue:6

    Topics: Animals; Bromodeoxyuridine; Cells, Cultured; Cytotoxicity, Immunologic; Female; Head and Neck Neoplasms; Humans; Inflammation; Mice; Monocytes; Neoplasms; Phytohemagglutinins; Thymidine; Tuberculosis, Pulmonary; Uterine Cervical Neoplasms

1981
In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region.
    Cell proliferation, 1995, Volume: 28, Issue:9

    Topics: Biomarkers, Tumor; Biopsy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Epithelial Cells; Head and Neck Neoplasms; Humans; Idoxuridine; Leydig Cell Tumor; Mucous Membrane; S Phase

1995
p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy.
    British journal of cancer, 1995, Volume: 71, Issue:6

    Topics: Aneuploidy; Biopsy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Disease-Free Survival; DNA, Neoplasm; Flow Cytometry; Genes, p53; Head and Neck Neoplasms; Humans; Immunohistochemistry; Kinetics; Neoplasm Recurrence, Local; Predictive Value of Tests; Treatment Outcome; Tumor Suppressor Protein p53

1995
A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck.
    The Journal of laryngology and otology, 1994, Volume: 108, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Ploidies; Prognosis; Proliferating Cell Nuclear Antigen; S Phase

1994
Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumour factors and survival.
    British journal of cancer, 1994, Volume: 69, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Cell Division; Chi-Square Distribution; DNA, Neoplasm; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitotic Index; Neoplasm Staging; Prognosis; Prospective Studies; S Phase; Survival Analysis; Survival Rate

1994
[Determination of potential doubling time using in vitro continuous labeling method with bromodeoxyuridine: estimation in head and neck squamous cell carcinoma].
    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1993, Aug-25, Volume: 53, Issue:8

    Topics: Brachytherapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Cell Division; Head and Neck Neoplasms; Humans; Tumor Cells, Cultured

1993
Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1995, Volume: 36, Issue:3

    Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunohistochemistry; Injections; Multivariate Analysis; Ploidies; Radiotherapy

1995
Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
    Cell proliferation, 1996, Volume: 29, Issue:3

    Topics: Antibody Specificity; Antigens, Neoplasm; Biomarkers, Tumor; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunohistochemistry; Ki-67 Antigen; Neoplasm Proteins; Nuclear Proteins; Population; Radiotherapy

1996
Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
    International journal of radiation oncology, biology, physics, 1996, Jun-01, Volume: 35, Issue:3

    Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Disease-Free Survival; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Multivariate Analysis; Neoplasm Staging; Oropharyngeal Neoplasms; Prospective Studies; Radiotherapy Dosage; Time Factors; Treatment Failure

1996
Cell proliferation and ploidy of human solid tumours: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry.
    Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology, 1996, Volume: 10, Issue:2

    Topics: Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Feasibility Studies; Female; Flow Cytometry; Gastrointestinal Neoplasms; Glioma; Head and Neck Neoplasms; Humans; Neoplasms; Ovarian Neoplasms; Ploidies; Uterine Neoplasms

1996
Comparative scoring by visual and image analysis of cells in human solid tumors labeled for proliferation markers.
    Cytometry, 1997, Feb-01, Volume: 27, Issue:2

    Topics: Bromodeoxyuridine; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Proliferating Cell Nuclear Antigen; Reproducibility of Results; Staining and Labeling; Urinary Bladder Neoplasms

1997
Comparison of mathematical formulas used for estimation of DNA synthesis time of bromodeoxyuridine-labelled cell populations with different proliferative characteristics.
    Cell proliferation, 1996, Volume: 29, Issue:10

    Topics: Adenocarcinoma; Animals; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cells, Cultured; DNA; Endometrial Neoplasms; Female; Fibroblasts; Flow Cytometry; Head and Neck Neoplasms; Humans; In Vitro Techniques; Kinetics; Lung; Mathematical Computing; Mice; Mice, Inbred BALB C; Mice, Nude; Sampling Studies; Time Factors; Tissue Transplantation; Tumor Cells, Cultured

1996
Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts.
    British journal of cancer, 1998, Volume: 77, Issue:1

    Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Flow Cytometry; Glioblastoma; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Mice, Nude; Microscopy; Radiation-Sensitizing Agents; Regional Blood Flow; Transplantation, Heterologous

1998
[Immunohistological studies on growth potential of head and neck carcinomas].
    Nihon Jibiinkoka Gakkai kaiho, 1998, Volume: 101, Issue:3

    Topics: Adult; Aged; Biomarkers, Tumor; Bromodeoxyuridine; Carcinoma, Squamous Cell; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Prognosis; S Phase

1998
Cell kinetics of head and neck cancers.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:5

    Topics: Biopsy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; DNA, Neoplasm; G2 Phase; Head and Neck Neoplasms; Humans; Idoxuridine; Kinetics; Lymphoma; Mitotic Index; S Phase; Time Factors

1995
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1999, Volume: 50, Issue:1

    Topics: Analysis of Variance; Antimetabolites; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA; Female; Flow Cytometry; Follow-Up Studies; Forecasting; Head and Neck Neoplasms; Humans; Idoxuridine; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Treatment Outcome

1999
Analysis of oxidative DNA damage and HPRT mutant frequencies in cancer patients before and after radiotherapy.
    Mutation research, 1999, Dec-17, Volume: 431, Issue:2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aged, 80 and over; Antioxidants; Biomarkers; Breast Neoplasms; Bromodeoxyuridine; Deoxyguanosine; DNA Damage; Female; Head and Neck Neoplasms; Humans; Hypoxanthine Phosphoribosyltransferase; Male; Micronucleus Tests; Middle Aged; Neoplasms; Oxidation-Reduction; Prostatic Neoplasms; Smoking

1999
Is there a future for cell kinetic measurements using IdUrd or BdUrd?
    International journal of radiation oncology, biology, physics, 2001, Feb-01, Volume: 49, Issue:2

    Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; DNA, Neoplasm; Esophageal Neoplasms; Follow-Up Studies; Forecasting; Head and Neck Neoplasms; Humans; Idoxuridine; Multicenter Studies as Topic; Neoplasm Staging; Ploidies; Time Factors

2001
Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
    The Laryngoscope, 2001, Volume: 111, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aneuploidy; Antibodies, Monoclonal; Antimetabolites; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Cell Cycle; Cell Differentiation; Chromogenic Compounds; Coloring Agents; Diploidy; Female; Flow Cytometry; Forecasting; Gene Expression Regulation, Neoplastic; Genes, p53; Head and Neck Neoplasms; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Statistics, Nonparametric; Survival Rate; Tumor Suppressor Protein p53

2001
Proliferative capacity in head and neck cancer.
    Head & neck, 2001, Volume: 23, Issue:6

    Topics: Antimetabolites, Antineoplastic; Bromodeoxyuridine; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Injections, Intravenous; Male; Middle Aged; Mitotic Index; Neoplasm Staging; Ploidies; Prospective Studies; Radiotherapy Dosage

2001
Cell kinetic changes in human squamous cell carcinomas during radiotherapy studied using the in vivo administration of two halogenated pyrimidines.
    European journal of cancer (Oxford, England : 1990), 2002, Volume: 38, Issue:8

    Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Feasibility Studies; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Idoxuridine; Male; Nucleic Acid Synthesis Inhibitors; Treatment Outcome

2002
Modulation of cell cycle kinetics in human cancer with total parenteral nutrition.
    Cancer, 1992, Apr-01, Volume: 69, Issue:7

    Topics: Adult; Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nutritional Status; Parenteral Nutrition, Total; S Phase

1992
Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
    British journal of cancer, 1992, Volume: 65, Issue:5

    Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Flow Cytometry; Head and Neck Neoplasms; Humans; Predictive Value of Tests; Prognosis; Prospective Studies; Reproducibility of Results; S Phase

1992
Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.
    British journal of cancer, 1992, Volume: 65, Issue:6

    Topics: Aneuploidy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; DNA, Neoplasm; Flow Cytometry; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Recurrence

1992
The use of bromodeoxyuridine cytokinetic studies as a prognostic indicator of cancer of the head and neck.
    The Laryngoscope, 1991, Volume: 101, Issue:2

    Topics: Adenoma; Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Prognosis; Staining and Labeling

1991
Optimal conditions for immunohistochemical determination of the in vitro DNA synthesis labelling index with bromodeoxyuridine in head and neck cancer.
    Cell proliferation, 1991, Volume: 24, Issue:6

    Topics: Biopsy; Bromodeoxyuridine; Cell Division; Cell Separation; DNA; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Mitotic Index; Prognosis

1991
Proliferative pattern of head and neck cancer.
    American journal of surgery, 1991, Volume: 162, Issue:4

    Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Mice; Mice, Inbred C57BL; Nuclear Proteins; Ribonucleotide Reductases

1991
Rapid in vitro bromodeoxyuridine labeling method for monitoring of therapy response in solid human tumors.
    Cytometry, 1990, Volume: 11, Issue:5

    Topics: Antineoplastic Agents; Bromodeoxyuridine; Carcinoma; Cell Cycle; Cisplatin; Colony-Forming Units Assay; DNA, Neoplasm; Epirubicin; Flow Cytometry; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Tumor Stem Cell Assay

1990
In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
    Journal of Korean medical science, 1989, Volume: 4, Issue:4

    Topics: Adenocarcinoma; Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Nucleus; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Interphase; Lymphoma; Neoplasms

1989
[Continuous superselective intra-arterial infusion with BUdR and 5 FU in combination with radiotherapy in the treatment of head and neck tumors].
    Gan no rinsho. Japan journal of cancer clinics, 1988, Volume: 34, Issue:13

    Topics: Bromodeoxyuridine; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Middle Aged; Radiotherapy Dosage

1988
[In-vivo marking of human tumors using BUDR for flow-cytometry determination of kinetic cell parameters].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1987, Volume: 163, Issue:3

    Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Interphase; Male; Ovarian Neoplasms; Sarcoma

1987
[Effect of BAR therapy in a case of malignant glioma with extracranial metastasis].
    No to shinkei = Brain and nerve, 1970, Volume: 22, Issue:10

    Topics: Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; DNA, Neoplasm; Head and Neck Neoplasms; Humans; Male; Neoplasm Metastasis; Radiation-Sensitizing Agents

1970